These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 22069520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
    Broche-Pierre S, Richardson J, Moraillon A, Sonigo P.
    J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.
    VandeWoude S, Hageman CL, Hoover EA.
    J Acquir Immune Defic Syndr; 2003 Sep 01; 34(1):20-31. PubMed ID: 14501789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
    Lombardi S, Garzelli C, Pistello M, Massi C, Matteucci D, Baldinotti F, Cammarota G, da Prato L, Bandecchi P, Tozzini F.
    J Virol; 1994 Dec 01; 68(12):8374-9. PubMed ID: 7966629
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH, Guevara RB, Marcano AC, Saenz DT, Fadel HJ, Rogstad DK, Poeschla EM.
    J Virol; 2014 Mar 01; 88(6):3255-72. PubMed ID: 24390322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
    Richards JR.
    Biologicals; 2005 Dec 01; 33(4):215-7. PubMed ID: 16257536
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H, Hofmann-Lehmann R, Bauer-Pham K, Holznagel E, Tozzini F, Bendinelli M, Reubel G, Aubert A, Davis D, Cox D.
    Vet Immunol Immunopathol; 1995 May 01; 46(1-2):103-13. PubMed ID: 7618250
    [Abstract] [Full Text] [Related]

  • 17. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
    Bęczkowski PM, Harris M, Techakriengkrai N, Beatty JA, Willett BJ, Hosie MJ.
    Vaccine; 2015 Feb 18; 33(8):977-84. PubMed ID: 25613718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.
    Pancino G, Camoin L, Sonigo P.
    J Virol; 1995 Apr 18; 69(4):2110-8. PubMed ID: 7884857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.